1991
DOI: 10.1016/s0028-3908(11)80008-0
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of insulin secretion by diazepam binding inhibitor and its processing products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
23
1

Year Published

1993
1993
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(26 citation statements)
references
References 17 publications
2
23
1
Order By: Relevance
“…Our results on insulin secretion are in agreement with a cytostatic effect of PK11195 reported in rodent islets (27), and with the inhibition of glucose-mediated insulin release associated with the incubation of rat islets with diazepam binding inhibitor (DBI), a putative endogenous PBR ligand (28). The mechanism(s) through which PK11195 exerts its inhibitory effect on insulin release was in part explored in the present study, and we showed that the cytostatic action was not due to grossly altered transcription of insulin or glucose-transporter GLUT-1 from the coding genes.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Our results on insulin secretion are in agreement with a cytostatic effect of PK11195 reported in rodent islets (27), and with the inhibition of glucose-mediated insulin release associated with the incubation of rat islets with diazepam binding inhibitor (DBI), a putative endogenous PBR ligand (28). The mechanism(s) through which PK11195 exerts its inhibitory effect on insulin release was in part explored in the present study, and we showed that the cytostatic action was not due to grossly altered transcription of insulin or glucose-transporter GLUT-1 from the coding genes.…”
Section: Discussionsupporting
confidence: 90%
“…Moreover, a recently described molecule, peripheral benzodiazepine receptor-associated protein (PRAX)-1, has been reported to have several domains involved in protein -protein interaction at the PBR level (36). Whereas the possible direct effects of PIX, anthralin and PRAX-1 on islet cells has not been tested, DBI has been shown to inhibit insulin release (28). More recently, upon construction of a human pancreatic islet cDNA library, screening of sera from diabetic patients led to the observation that one of the generated clones was strongly related to DBI (37).…”
Section: Discussionmentioning
confidence: 99%
“…ACBP is reported to play a role in a number of important physiological and biochemical functions, such as regulation of glucose-induced insulin secretion from pancreatic β-cells (32,33), stimulation of steroidogenesis through peripheral-type benzodiazepine receptor (PBR) (34)(35)(36), and modulation of cell proliferation (37). ACBP/DBI, originally described as a cytosolic protein and identified as stimulating the synthesis of pregnenolone in mitochondrial fractions, enhances steroidogenesis via PBRs.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, elevated levels of a diazepam binding inhibitor-like immunoreactive compound have been reported in patients diagnosed with depression with concomitant anxiety (26). Diazepam binding inhibitor has been previously shown to inhibit glucose-stimulated insulin release from pancreatic islet > cells (28,29). Suk et al (30) demonstrated that cDNA related to diazepam binding inhi- bitor was expressed in most tissues including liver, lung, tonsil and thymus, in addition to pancreatic islet and sera, in diabetic patients.…”
Section: Discussionmentioning
confidence: 99%